Corey Williams
Corey Williams's Latest Posts
BST Trade Alert: June 6, 2013
June 6, 2013 Recommendation: Buy Rockwell Medical (NASDAQ: RMTI) up to $4.40 per share. About the Company: Before we tell you all about today’s biotech pick, we’d like to briefly explain our strategy for this trade. You see, we’re taking a different approach than we normally do with our biotech recommendations. As you probably know, most of […]
SET Portfolio Update June 2013
June 4, 2013 Dear Sector ETF Trader Reader, It’s been another solid month for the stock market. In fact, eight of our open trades hit new highs since the last issue came out just two weeks ago. But it hasn’t been all sunshine and teddy bears for investors… Fed Chairman Ben Bernanke knocked the wind […]
BST Trade Alert: May 28, 2013
May 28, 2013 Recommendation: Buy BioLineRx (NASDAQ: BLRX) up to $1.85 per share. About the Company: BioLineRx is a fascinating Israeli biotech. The company was founded in 2003 by Teva Pharmaceuticals (NYSE: TEVA), a global leader in the generic drug industry with a market cap of $33 billion. Just four years later it completed an IPO and began trading […]
SET Monthly Issue May 2013
May 2013 ECONOMIC GROWTH OR NOT – STOCKS ARE ON FIRE! The S&P 500’s 28% year-to-date rally is impressive. But it’s even more astounding when you dig a little deeper into the economic data. In short, lackluster economic data doesn’t seem to support such a meteoric rise for stocks. Yet, here we are with stocks […]
BST Position Update: May 16, 2013
May 16, 2013 . . . . AcelRx Pharmaceuticals (NASDAQ: ACRX) – Sell ACRX is on fire! The biotech’s shares soared to a new high of $7.30 just yesterday. Investors have clearly piled into the stock ahead of the upcoming phase 3 trial data for ARX-01. Those results are expected before the end of the […]
SET Portfolio Update May 2013
May 7, 2013 Dear Sector ETF Trader Reader, There’s no doubt about it – The S&P 500 is on a roll. The large cap index is up 14% year-to-date and it’s hitting fresh all-time highs again this week. And if you include dividends, the S&P 500 has been up 10 out of the last 11 […]
BST Trade Alert: April 17, 2013
April 17, 2013 Recommendation: Buy Synergy Pharmacetucials (NASDAQ: SGYP) up to $6.00 per share. About the Company: Synergy Pharmaceuticals is a development-stage biotech with a potentially super-nova bright future. The company’s financial condition is rock solid. Their leading drug candidate might just be a better option for patients than the current FDA approved treatment. And the drug’s […]
SET Monthly Issue April 2013
April 2013 IS THE TREND OUR FRIEND? As you know, the S&P has started off the year with a bang. Even after yesterday’s selloff, the large cap index has raced out to a 10% gain. In fact, the recent rally sent the S&P to a high of 1,597 – the highest level ever recorded! One […]
BST Position Update: April 4, 2013
April 4, 2013 . . . . AcelRx Pharmaceuticals (NASDAQ: ACRX) – Buy up to $5.65 ACRX is the latest addition to the portfolio. They’re developing the Sufentanil NanoTab® PCA system (also known as ARX-01) which allows patients to manage their post-operative pain following surgery. At the moment, surgical patients manage their post-operative pain with […]
SET Portfolio Update April 2013
April 2, 2013 Dear Sector ETF Trader Reader, It finally happened… After flirting with new all-time highs over the last few weeks, the S&P 500 finally broke through last week. The large cap index closed at a new all-time high before the markets shut down for a three day weekend. The significance of the breakout […]
